Maternal and Fetal Outcome With Metformin Therapy for Obese Pregnant Women .

• Status: Recruiting
• Trial end date: 2022-10-22
• Target enrollment: 0
• Participant gender: Female

Summary

To evaluate the role of metformin in pregnant women with obesity (BMI above 30) , on maternal and infant outcome.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Metformin

Criteria

Inclusion Criteria:

• pregnant women with BMI ≥ 30 kg/m2, and normal glucose tolerance test.

Exclusion Criteria:

• pregnant women who are diabetic,

• had a history of previous GDM,

• previous small baby,

• PCO or

• previous early pre-eclampsia,